Track the Max Healthcare Institute Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Max Healthcare Institute Limited has logged 141 reports. Market capitalisation: €1,069.1bn. The latest transaction was filed on 26 August 2022 (Purchase). Among the most active insiders: Kayak Investments Holding Pte. Ltd.. The full history is accessible without an account.
141
Insider Decl.
n/a
Thresholds
€730,166
81 ops.
Buy Volume
€2bn
25 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Max Healthcare Institute Limited Buy (bullish), based on 26 analysts. Average price target: ₹1,172.62.
10Σ signal
Buys €730,166€2bn Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,402 of 29,016 companies
52.2
score / 100
Value
28
Quality
77
FCF yld0.1%
Earn yld1.3%
EV/EBITDA47.2x
ROE14%
Gross mgn78%
Net mgn18%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
25,075 shares@ ₹373.2595.0% of flowEquity SharesSEBI:ac5290b93ca89a7b6858965fe5d5e85d04278b61
25 of 141 declarations
About Max Healthcare Institute Limited
Max Healthcare Institute Limited is an Indian company operating in the healthcare and pharmaceutical sector. It provides high-quality medical services and healthcare through its hospitals and clinics.